Decreased human respiratory syncytial virus activity during the COVID-19 pandemic in Japan: an ecological time-series analysis.
COVID-19
Epidemics
HRSV
NPIs
SARS-CoV-2
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
03 Aug 2021
03 Aug 2021
Historique:
received:
11
05
2021
accepted:
21
07
2021
entrez:
4
8
2021
pubmed:
5
8
2021
medline:
25
9
2021
Statut:
epublish
Résumé
Non-pharmaceutical interventions (NPIs), such as sanitary measures and travel restrictions, aimed at controlling the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), may affect the transmission dynamics of human respiratory syncytial virus (HRSV). We aimed to quantify the contribution of the sales of hand hygiene products and the number of international and domestic airline passenger arrivals on HRSV epidemic in Japan. The monthly number of HRSV cases per sentinel site (HRSV activity) in 2020 was compared with the average of the corresponding period in the previous 6 years (from January 2014 to December 2020) using a monthly paired t-test. A generalized linear gamma regression model was used to regress the time-series of the monthly HRSV activity against NPI indicators, including sale of hand hygiene products and the number of domestic and international airline passengers, while controlling for meteorological conditions (monthly average temperature and relative humidity) and seasonal variations between years (2014-2020). The average number of monthly HRSV case notifications in 2020 decreased by approximately 85% (p < 0.001) compared to those in the preceding 6 years (2014-2019). For every average ¥1 billion (approximately £680,000/$9,000,000) spent on hand hygiene products during the current month and 1 month before there was a 0.29% (p = 0.003) decrease in HRSV infections. An increase of average 1000 domestic and international airline passenger arrivals during the previous 1-2 months was associated with a 3.8 × 10 This study suggests that there is an association between the decrease in the monthly number of HRSV cases and improved hygiene and sanitary measures and travel restrictions for COVID-19 in Japan, indicating that these public health interventions can contribute to the suppression of HRSV activity. These findings may help in public health policy and decision making.
Sections du résumé
BACKGROUND
BACKGROUND
Non-pharmaceutical interventions (NPIs), such as sanitary measures and travel restrictions, aimed at controlling the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), may affect the transmission dynamics of human respiratory syncytial virus (HRSV). We aimed to quantify the contribution of the sales of hand hygiene products and the number of international and domestic airline passenger arrivals on HRSV epidemic in Japan.
METHODS
METHODS
The monthly number of HRSV cases per sentinel site (HRSV activity) in 2020 was compared with the average of the corresponding period in the previous 6 years (from January 2014 to December 2020) using a monthly paired t-test. A generalized linear gamma regression model was used to regress the time-series of the monthly HRSV activity against NPI indicators, including sale of hand hygiene products and the number of domestic and international airline passengers, while controlling for meteorological conditions (monthly average temperature and relative humidity) and seasonal variations between years (2014-2020).
RESULTS
RESULTS
The average number of monthly HRSV case notifications in 2020 decreased by approximately 85% (p < 0.001) compared to those in the preceding 6 years (2014-2019). For every average ¥1 billion (approximately £680,000/$9,000,000) spent on hand hygiene products during the current month and 1 month before there was a 0.29% (p = 0.003) decrease in HRSV infections. An increase of average 1000 domestic and international airline passenger arrivals during the previous 1-2 months was associated with a 3.8 × 10
CONCLUSIONS
CONCLUSIONS
This study suggests that there is an association between the decrease in the monthly number of HRSV cases and improved hygiene and sanitary measures and travel restrictions for COVID-19 in Japan, indicating that these public health interventions can contribute to the suppression of HRSV activity. These findings may help in public health policy and decision making.
Identifiants
pubmed: 34344351
doi: 10.1186/s12879-021-06461-5
pii: 10.1186/s12879-021-06461-5
pmc: PMC8329631
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
734Informations de copyright
© 2021. The Author(s).
Références
Nature. 2020 Aug;584(7820):257-261
pubmed: 32512579
J Clin Med. 2020 Feb 24;9(2):
pubmed: 32102279
Lancet. 2020 Feb 22;395(10224):542-545
pubmed: 32061313
BMC Public Health. 2021 Jun 23;21(1):1196
pubmed: 34158019
Lancet Public Health. 2020 May;5(5):e261-e270
pubmed: 32220655
PLoS One. 2021 Mar 25;16(3):e0248932
pubmed: 33765037
Epidemiol Infect. 2017 Jan;145(2):272-284
pubmed: 27682641
Travel Med Infect Dis. 2021 Mar-Apr;40:101997
pubmed: 33640476
J Infect. 2020 Jul;81(1):107-114
pubmed: 32335167
J Infect. 2020 Sep;81(3):e24-e25
pubmed: 32650109
PLoS One. 2020 Oct 9;15(10):e0239254
pubmed: 33035219
Lancet. 2020 Feb 15;395(10223):470-473
pubmed: 31986257
Singapore Med J. 2003 Dec;44(12):614-9
pubmed: 14770254
Proc Natl Acad Sci U S A. 2020 Dec 1;117(48):30547-30553
pubmed: 33168723
Rev Med Virol. 2014 Jan;24(1):15-34
pubmed: 24421259
Am J Infect Control. 2009 Dec;37(10):827-34
pubmed: 20004812
Int J Infect Dis. 2020 May;94:139-144
pubmed: 32283285
BMC Infect Dis. 2009 Mar 11;9:27
pubmed: 19284571
Clin Infect Dis. 2021 Jun 15;72(12):2071-2075
pubmed: 32986818
Lancet Glob Health. 2020 Apr;8(4):e488-e496
pubmed: 32119825
Lancet. 2020 Mar 21;395(10228):931-934
pubmed: 32164834
Influenza Other Respir Viruses. 2020 Nov;14(6):757-758
pubmed: 32875675
Lancet Public Health. 2020 May;5(5):e279-e288
pubmed: 32311320
PLoS One. 2019 Feb 21;14(2):e0212687
pubmed: 30789963
Sci Rep. 2020 Jul 2;10(1):10931
pubmed: 32616819
Curr Treat Options Infect Dis. 2016;8(4):311-328
pubmed: 28035195
Lancet Glob Health. 2021 Jan;9(1):e33-e43
pubmed: 33248481
Emerg Infect Dis. 2020 Aug;26(8):1933-1935
pubmed: 32339092
J Infect. 2021 Mar;82(3):414-451
pubmed: 33039503
Emerg Infect Dis. 2020 Aug;26(8):1928-1930
pubmed: 32339091
Sci Rep. 2015 Sep 30;5:14268
pubmed: 26420660
Jpn J Infect Dis. 2021 Mar 24;74(2):157-160
pubmed: 32863355
Pediatr Rev. 2014 Dec;35(12):519-30
pubmed: 25452661
Epidemiol Infect. 2007 Oct;135(7):1077-90
pubmed: 17346359
Lancet Infect Dis. 2013 Oct;13(10):843-51
pubmed: 23972825
J Infect Dis. 2017 Jan 1;215(1):17-23
pubmed: 27738052
J Infect. 2021 Jun;82(6):276-316
pubmed: 33581238
Nat Commun. 2021 May 31;12(1):3249
pubmed: 34059675
J Infect. 2021 Jan;82(1):133-142
pubmed: 33275956
Am J Public Health. 2008 Aug;98(8):1372-81
pubmed: 18556606
Int J Infect Dis. 2020 Aug;97:78-80
pubmed: 32492532
Nature. 2020 Sep;585(7825):410-413
pubmed: 32365354
Epidemiol Infect. 2018 Apr;146(6):757-762
pubmed: 29560833
Epidemiol Infect. 2021 Feb 11;149:e55
pubmed: 33568242
Am J Trop Med Hyg. 2011 May;84(5):757-63
pubmed: 21540386
Int J Infect Dis. 2021 Jan;102:247-253
pubmed: 33129965
Epidemiol Infect. 2010 Feb;138(2):226-35
pubmed: 19631018
J Pediatr. 2003 Oct;143(4):532-40
pubmed: 14571236
SAGE Open Med. 2021 Jun 6;9:20503121211022973
pubmed: 34164126
Pediatr Infect Dis J. 2020 Dec;39(12):e423-e427
pubmed: 32773660
Sci Rep. 2021 Feb 4;11(1):3109
pubmed: 33542248
PLoS One. 2018 Jan 29;13(1):e0192085
pubmed: 29377949
J Infect. 2020 Aug;81(2):e159-e161
pubmed: 32534000
Public Health. 2011 Jun;125(6):368-76
pubmed: 21616514
Lancet. 2010 May 1;375(9725):1545-55
pubmed: 20399493
Glob Health Action. 2014 Aug 12;7:24413
pubmed: 25128806
Int J Infect Dis. 2020 Jul;96:371-375
pubmed: 32425637
Lancet Infect Dis. 2018 Oct;18(10):e295-e311
pubmed: 29914800
Jpn J Infect Dis. 2020 Sep 24;73(5):391-393
pubmed: 32350228
Trop Med Int Health. 2009 Dec;14(12):1534-41
pubmed: 19793069
Pediatr Res. 2021 May;89(7):1664-1672
pubmed: 33510411
Lancet Reg Health West Pac. 2020 Aug;1:100011
pubmed: 34173594
Emerg Infect Dis. 2021 Mar;27(3):915-918
pubmed: 33622475
Emerg Infect Dis. 2020 Sep;26(9):
pubmed: 32521222
MMWR Morb Mortal Wkly Rep. 2020 Sep 18;69(37):1305-1309
pubmed: 32941415
Influenza Other Respir Viruses. 2020 Nov;14(6):647-657
pubmed: 31670892
Bull World Health Organ. 2020 Aug 1;98(8):518-529
pubmed: 32773897
J Infect. 2020 Dec;81(6):e19-e21
pubmed: 32810519
J Infect. 2021 Feb;82(2):282-327
pubmed: 32956735
Lancet Infect Dis. 2021 Feb;21(2):193-202
pubmed: 33729915
Lancet Glob Health. 2019 Aug;7(8):e1031-e1045
pubmed: 31303294
Sci Adv. 2018 Oct 03;4(10):e1700741
pubmed: 30306126
Proc Natl Acad Sci U S A. 2020 Mar 31;117(13):7504-7509
pubmed: 32170017
Trop Med Int Health. 2006 Mar;11(3):258-67
pubmed: 16553905
Nat Hum Behav. 2020 Dec;4(12):1303-1312
pubmed: 33199859
PLoS One. 2012;7(3):e32807
pubmed: 22470426
Lancet Reg Health West Pac. 2020 Oct;3:100016
pubmed: 34173599
Sci Rep. 2020 Nov 24;10(1):20469
pubmed: 33235232
JAMA. 2020 May 19;323(19):1969-1971
pubmed: 32275293
Science. 2020 Apr 24;368(6489):395-400
pubmed: 32144116